Clinical Trial Update: Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of 25-hydroxyvitamin D in haemodialysis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• 25-Hydroxyvitamin D (25-hydroxyvitamin D)

Snippet

Sponsor: Italian Society of Nephrology | Conditions: Chronic Renal Failure | Phase 3 | Status: TERMINATED